Nephrogenic systemic fibrosis: Difference between revisions
CSV import Tag: Reverted |
No edit summary Tag: Manual revert |
||
| Line 36: | Line 36: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
Revision as of 13:00, 18 March 2025
Nephrogenic systemic fibrosis (NSF) is a rare medical condition that affects the skin and internal organs. It is primarily associated with individuals who have advanced kidney disease or kidney failure. The condition is characterized by the thickening and hardening of the skin, often resulting in reduced mobility.
Symptoms
The symptoms of NSF can vary greatly from person to person. The most common symptoms include:
- Skin thickening and hardening
- Joint stiffness and pain
- Muscle weakness
- Swelling and redness of the skin
- Skin discoloration
Causes
The exact cause of NSF is unknown, but it is believed to be linked to exposure to gadolinium, a chemical used in certain types of MRI scans. Individuals with advanced kidney disease or kidney failure are at a higher risk of developing NSF after exposure to gadolinium.
Diagnosis
Diagnosis of NSF is typically based on a physical examination and the patient's medical history. In some cases, a skin biopsy may be performed to confirm the diagnosis.
Treatment
There is currently no cure for NSF, but treatments can help manage symptoms and slow the progression of the disease. Treatment options may include:
Prognosis
The prognosis for individuals with NSF can vary greatly depending on the severity of the disease and the individual's overall health. In some cases, NSF can lead to severe disability or even death.


